| Non-Small Cell Adenocarcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived57 of 57show fewer |
|---|
| → investigated in trials for | Carboplatinsmall molecule 20 trials (7 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 18 trials (2 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 15 trials (4 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemetrexedsmall molecule 15 trials (4 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 13 trials (2 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 9 trials (5 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 8 trials (5 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinib Hydrochloridesmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gefitinibsmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cetuximabmonoclonal antibody 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Firmonertinibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Metforminsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Binimetinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Icotinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Osimertinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegfilgrastimother 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Poziotinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinorelbinesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abemaciclibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Akt Inhibitor MK2206 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alpelisibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aspirinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camrelizumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capmatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ceritinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cixutumumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Crizotinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hydroxychloroquinesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lorlatinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Luminespibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nintedanibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Palbociclibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pentostatinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ponatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rucaparibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sintilimabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sirolimussmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sotorasibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tovorafenibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trametinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Small Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |